Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. Queensland was the source of 51% of prescriptions between 2016 and 2021.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Project CBD

JANUARY 24, 2019

In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Around 10-20% of patients stopped taking various medications (mostly antipsychotic and antiepileptic drugs) within 6 months of starting cannabis treatment. Cannabis and ADHD.

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? According to a 2016 study , about 39.3% of patients experience pain after curative treatment, while 66.4% in cancer patients undergoing anticancer treatment, 50.7% years between May 2015 and October 2018.

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Medicinal cannabis as a last resort.

Medicine 52

Medicine Clinical Trials Sleep Data 52

The Cannigma

JUNE 30, 2021

In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% The most common medical conditions. In Colorado, 78.7%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

CannaMD

NOVEMBER 22, 2020

For those who suffer from migraine pain, the excruciating condition can be completely debilitating, impossible to manage without a dark room, a cool cloth over the eyes, and sublime silence. Patients used the app, Strainprint, which allowed data to be archived and studied. and migraine severity by 49.6%. Find Out if You Qualify.

Marijuana 116

Marijuana Treatment Patients Cannabinoids 116

Peninsula Alternative Health

MARCH 1, 2018

In 2016, Maryland contracted with ASA’s Patient Focused Certification program to train the officials tasked with watching over the state’s emerging medical cannabis program. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

In 2016, Maryland contracted with ASA’s Patient Focused Certification program to train the officials tasked with watching over the state’s emerging medical cannabis program. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data.

Treatment 40

Treatment Education Advocacy Access 40

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. Research published in 2016 revealed that 59% of a sample of patients who misused opioids were first exposed to them through a medical prescription. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

CannaMD

DECEMBER 8, 2020

Between 2016-2018, despite rapidly expanding state legalization, there was a slight increase in marijuana-related arrests year over year. In 2019, for example, FBI data shows 495,871 arrests made for violent crime – compared to the 500,395 individuals who were arrested for marijuana possession with no additional charges. Get Started.

Marijuana 105

Marijuana Chronic Pain Treatment Legalization 105

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. In November of 2016, 71% of Florida voters approved the Florida Medical Marijuana Legalization Initiative (perhaps confusingly: also known as Amendment 2 ). .’

Law 126

Law Marijuana Patients Treatment 126

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. Some patients report relief from chronic pain conditions, such as neuropathy, arthritis, and fibromyalgia, when using cannabis products.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

FEBRUARY 17, 2020

Although their personal CME physician can make recommendations on product choices or dispensaries that would be best for the patients qualifying condition and associated symptoms, patients are not required to purchase specific cannabis products. . On the popular MarijuanaDoctors.com , all qualifying conditions in Florida are noted.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Veriheal

JULY 5, 2021

Titled “ The Effectiveness of Common Cannabis Products for Treatment of Nausea ”, the newly published study indicates that most medical cannabis patients who endure nausea prefer to load up on THC, as opposed to CBD. The self-reported data was logged between June 6, 2016, and July 8, 2019. Gastrointestinal conditions.

THC 52

THC CBD Treatment Cannabinoids 52

Canabo Medical Clinic

NOVEMBER 29, 2018

Some studies suggest those using opioid medications can even reduce or eliminate their dependence on these substances by introducing medical marijuana to their treatment plans. The number of authorizations grew exponentially in 2016, and authorizations continued apace in 2017. The Number of Opioid Prescriptions Is Increasing.

Patients 40

Patients Data Conditions Cannabis 40

Cannabis Law Report

JUNE 8, 2022

MDMA-assisted therapy, a novel treatment for PTSD with FDA breakthrough therapy designation, is on track for NDA submission in 2023 pending results of the confirmatory Phase 3 trial. He previously served as the global CEO for both Sandoz and Alcon, at Novartis Group, where he served on the Executive Committee from 2008 to 2016.

Therapy 52

Therapy Treatment Access Patients 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Fast Track review is for drugs that treat serious conditions and fill an unmet medical need. Defining Psychedelics. Approval Pathways.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. Mental health treatment is big business, with the global antidepressant drug market valued at over $13 billion in 2016.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 billion by 2029.

Research and Development 52

Research and Development Legalization Treatment Patients 52

CannaMD

NOVEMBER 6, 2019

In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 Medical cannabis is an effective and safe alternative for pain treatment. million to 11.4

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Greencamp

FEBRUARY 2, 2019

Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids. 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

JULY 28, 2021

Andy served as University of Alberta Associate Vice President (Research) and was a member of the Scientific Advisory Board of the CIHR Institute of Neuroscience Mental Health & Addiction from 2012-2016. “We would like to extend a warm welcome to Andy as he joins the team at Entheon. ” About Entheon Biomedical Corp.

Research and Development 105

Research and Development Events Media Data 105

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.

Patients 98

Patients Education Marijuana Therapy 98

Freedom Leaf

OCTOBER 15, 2018

This move reinforced a federal ruling on April 16 that affirmed the December 2016 DEA decision to create a new Schedule I code for cannabis extracts, including CBD extracts. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

JUNE 26, 2019

“The purpose of this Programme is to facilitate compassionate access to cannabis for medical reasons, where conventional treatment has failed. Patients with a specified medical condition should see their medical consultant for advice. It is important to state that there are no plans to legalise cannabis in this country.”.

Medicine 55

Medicine Access Business Legislation 55

Cannabis Law Report

NOVEMBER 29, 2019

Medical marijuana uses the cannabis plant or its basic chemicals to treat a whole bunch of different diseases and conditions. When it comes to CBD, it shows promise as a potential new treatment for schizophrenia. Still, the data is quite superficial. The cannabis plant contains more than 500 identified chemical constituents.

Research and Development 59

Research and Development THC Cannabinoids CBD 59

Veriheal

OCTOBER 5, 2020

The bill set out the qualifying conditions as well as regulations relating to possession, cultivation, and dispensaries. Hawaii legalized cannabis in its’ House Bill 2729 which was passed in 2018. Complimentary to the act, Senate Bill 321 was established in order to address the legal acquisition of cannabis through a legal dispensary system.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

CannaTech

OCTOBER 14, 2018

However, when Proposition 64 passed in 2016, effectively legalizing recreational marijuana use, an unfortunate side effect was the inability to differentiate industrial hemp from its psychoactive counterpart, cannabis. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. In the U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Project CBD

JUNE 20, 2023

Food and Drug Administration, three are prescribed for the treatment of chemotherapy-induced nausea and vomiting. One gastrointestinal condition long associated with self-medication through cannabis is inflammatory bowel disease (IBD). But gastrointestinal symptoms, such as nausea and upset stomach, aren’t far behind.

Cannabinoids 208

Cannabinoids Patients Treatment Conditions 208

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

SEPTEMBER 27, 2021

New York, with approximately 15 million residents over the age of 21, first launched its medical cannabis program in 2016, which has generally been considered restrictive, with fewer qualifying medical conditions and other restrictions which have inhibited growth of the regulated medical cannabis market in the fourth largest state by population.

Programs 52

Programs Patients Cultivation Dispensary 52

Canna Care Docs

JULY 29, 2019

She said it “just barely covers the pain” of her condition. A recently released study out of New York University, supported by the National Institute on Drug Abuse, looked at data from the National Survey on Drug Use and Health, an annual survey of 70,000 Americans of all ages. Around Christmastime last year, Ms.

Chronic Pain 53

Chronic Pain Sleep Education Dispensary 53

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

JULY 30, 2019

The same cannot be said for opioid treatment. These physicians strive to ease pain, treat more qualifying conditions, and to help patients make informed decisions about cannabis medicine, and make wise product use self-guidelines at home. Seen different doctors for a qualifying condition? As for the future? No problem!

Marijuana 40

Marijuana Education Patients Research and Development 40

SpeedWeed

MARCH 6, 2021

Florida for Care Executive Director Ben Pollara, the legalization advocate who helped lead Florida’s successful medical marijuana campaign in 2016, pointed out another problem in a recent op-ed published in the Fort Myers News-Press. Forcing patients to purchase more. Florida State Sen. Another way to prohibit cannabis.

THC 52

THC Patients Law Chronic Pain 52

Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K. About Silver Spike Capital.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

JUNE 2, 2022

More recently, Silvaggio points to the controversy surrounding the passage in 2016 of California’s Proposition 64 , which legalized cultivation and use by adults in the state, as an example of how legislation helps foster unintentional environmental consequences. Image by Matteo Paganelli via Unsplash.

Legalization 52

Legalization Cultivation Cannabis Environment 52